United States Patent and Trademark Office OG Notices: 25 September 2007
Summary of Final Decisions Issued by the Trademark Trial and Appeal Board
August 20-24, 2007
Date Type of Proceeding
Issued Case (1) or App'n No. Party/Parties
8-20 OPP 91161603 Allergan, Inc. v.
BioCentric
Laboratories, Inc.
Opposer's/ Applicant's/
Petitioner's Respondent's
TTAB Mark and Mark and
Issue Decision Goods/Services Goods/Services
2(d) Opposition "BOTOX" "SEATOX"
Sustained [pharmaceutical [cosmetics]
preparations, namely,
ophthalmic muscle
relaxants;
pharmaceutical
preparations for the
treatment of
neurological disorders,
muscle dystonias,
smooth muscle
disorders, autonomic
nerve disorders,
headaches, wrinkles,
hyperhydrosis, sports
injuries, cerebral
palsy, spasms, tremors
and pain]
Mark and Citable as
Goods Cited by Precedent
Examining Atty. of TTAB
No
(1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT
USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION; (MD)=MOTION
TO DISMISS; (MR)=MOTION TO REOPEN